Advertisement

Organisation › Details
Sigrid Therapeutics AB
![]() |
Start | 2014-01-01 established |
![]() |
Industry | antidiabetic |
Industry 2 | SiPore15™ medical device (SiPore® technology) | |
![]() |
Person | Alajmovic, Sana (Sigrid Therapeutics 201909 CEO + Co-Founder) |
![]() |
Region | Stockholm |
Country | Sweden | |
Street | 159 Sankt Göransgatan | |
City | 11217 Stockholm | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | n. a. |
Record changed: 2023-07-10 |
Advertisement

More documents for Sigrid Therapeutics AB
- [1] Sigrid Therapeutics AB. (1/16/23). "Press Release: Sigrid Therapeutics Raises further SEK10.6 Million in Oversubscribed Rights Issue for Accelerated SiPore Commercialization". Stockholm....
- [2] Sigrid Therapeutics AB. (9/5/19). "Press Release: Stockholm-based Technology Startup Sigrid Therapeutics, Developing SiPore15 – a Breakthrough Device to Lower Blood Sugar Levels, Closes Oversubscribed Round of $1.6m, Bringing Total Pre-launch Funding to...
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top